These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 1347278)

  • 61. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
    Drumm B; Sherman P; Chiasson D; Karmali M; Cutz E
    J Pediatr; 1988 Nov; 113(5):908-12. PubMed ID: 3183851
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer.
    Eberhardt R; Kasper G
    Rev Infect Dis; 1990; 12 Suppl 1():S115-9. PubMed ID: 2406852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.
    Weston AP; Campbell DR; McGregor DH; Cherian R
    Dig Dis Sci; 1994 Dec; 39(12):2567-74. PubMed ID: 7995181
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of Helicobacter pylori-associated gastroduodenal disease in children. Clinical evaluation of antisecretory vs antibacterial therapy.
    Rosioru C; Glassman MS; Berezin SH; Bostwick HE; Halata M; Schwarz SM
    Dig Dis Sci; 1993 Jan; 38(1):123-8. PubMed ID: 8093598
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pylorid, H. pylori and peptic ulcer.
    Drug Ther Bull; 1996 Sep; 34(9):69-70. PubMed ID: 8885498
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens.
    Fraser AG; Lam WM; Luk YW; Sercombe J; Sawyerr AM; Hudson M; Samloff IM; Pounder RE
    Gut; 1993 Mar; 34(3):338-42. PubMed ID: 8472980
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Colloidal bismuth subcitrate and two different dosages of cimetidine in the treatment of resistant duodenal ulcer. Preliminary results.
    Bianchi Porro G; Parente F; Lazzaroni M; Pace F
    Scand J Gastroenterol Suppl; 1986; 122():39-41. PubMed ID: 2877490
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound.
    Mysore JV; Wigginton T; Simon PM; Zopf D; Heman-Ackah LM; Dubois A
    Gastroenterology; 1999 Dec; 117(6):1316-25. PubMed ID: 10579973
    [TBL] [Abstract][Full Text] [Related]  

  • 69. H. pylori and ulcers.
    McGuffey EC
    Am Pharm; 1994 Jul; NS34(7):21. PubMed ID: 8085532
    [No Abstract]   [Full Text] [Related]  

  • 70. Mucoadhesive effect of Curcuma longa extract and curcumin decreases the ranitidine effect, but not bismuth subsalicylate on ethanol-induced ulcer model.
    Orona-Ortiz A; Medina-Torres L; Velázquez-Moyado JA; Pineda-Peña EA; Balderas-López JL; Bernad-Bernad MJ; Tavares Carvalho JC; Navarrete A
    Sci Rep; 2019 Nov; 9(1):16622. PubMed ID: 31719599
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers.
    Lee FI; Samloff IM; Hardman M
    Lancet; 1985 Jun; 1(8441):1299-302. PubMed ID: 2860494
    [TBL] [Abstract][Full Text] [Related]  

  • 72. H2-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients.
    Meining A; Bosseckert H; Caspary WF; Nauert C; Stolte M
    Aliment Pharmacol Ther; 1997 Aug; 11(4):729-34. PubMed ID: 9305482
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Can higher doses of an H2-receptor antagonist accelerate duodenal ulcer healing?
    Page MC; Lacey LA; Mills JG; Wood JR
    Aliment Pharmacol Ther; 1989 Oct; 3(5):425-33. PubMed ID: 2577498
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study.
    Koulinska I; Riester K; Chalkias S; Edwards MR
    Clin Ther; 2018 Dec; 40(12):2021-2030.e1. PubMed ID: 30447891
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevention of diarrhea caused by enterotoxigenic Escherichia coli: lessons learned with volunteers.
    Graham DY; Evans DG
    Rev Infect Dis; 1990; 12 Suppl 1():S68-72. PubMed ID: 2406859
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea.
    DuPont HL; Flores Sanchez J; Ericsson CD; Mendiola Gomez J; DuPont MW; Cruz Luna A; Mathewson JJ
    Am J Med; 1990 Jun; 88(6A):15S-19S. PubMed ID: 2192553
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori.
    McNulty CA
    Rev Infect Dis; 1990; 12 Suppl 1():S94-8. PubMed ID: 2406863
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Helicobacter pylori positive resistant duodenal ulcers.
    Guslandi M
    Gut; 1993 Nov; 34(11):1646-7; author reply 1647-8. PubMed ID: 8244159
    [No Abstract]   [Full Text] [Related]  

  • 79. Treatment of duodenal ulcer with sucralfate.
    Lam SK
    Scand J Gastroenterol Suppl; 1991; 185():22-8. PubMed ID: 1683491
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
    Lacey LF; Frazer NM; Keene ON; Smith JT
    Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.